Verici’s $8.2m gross raise means the company can now focus on scaling Tutivia and invest further into the development of existing and new products. With a uniquely well balanced Tutivia test, a growing sales team and LCD coverage expected later this year, we forecast Tutivia revenues of $2.6m/$4.5m in FY24E/FY25E. The Thermo Fisher deal was a huge validation of Clarava and Verici’s technology and in addition to licensing/milestone payments, we forecast double digit royalties on net Clarava sales ....
25 Mar 2024
$8.2m gross raise primes Verici for commercialisation
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
$8.2m gross raise primes Verici for commercialisation
Verici Dx Plc (VRCI:LON) | 0 0 0.0% | Mkt Cap: 17.6m
- Published:
25 Mar 2024 -
Author:
Edward Sham -
Pages:
3
Verici’s $8.2m gross raise means the company can now focus on scaling Tutivia and invest further into the development of existing and new products. With a uniquely well balanced Tutivia test, a growing sales team and LCD coverage expected later this year, we forecast Tutivia revenues of $2.6m/$4.5m in FY24E/FY25E. The Thermo Fisher deal was a huge validation of Clarava and Verici’s technology and in addition to licensing/milestone payments, we forecast double digit royalties on net Clarava sales ....